Ovarian cancer drug approved for NHS use will prolong lives

Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.

Related

Other articles with overlapping topics.

T

The Conversation

Killing cancer requires immune cells to infiltrate tumors’ hostile microenvironment – sugar shields can help them break in

CAR-T therapy engineers a patient’s own immune cells to fight cancer. Making these cels more resilient can make treatments more effective.

Lee Seng Lau, Postdoctoral Associate in Cellular and Molecular Medicine, Florida International University·Jun 12, 2026

T

The Conversation

Baby slings: what the evidence says about benefits, risks and safe use

New research finds that baby slings offer important benefits, but better safety information could help prevent rare deaths and injuries.

Sophie Lovell-Kennedy, PhD Student/Durham Infancy and Sleep Centre Co-Manager, Durham University·Jun 12, 2026

Nautilus

The Healing Power of Dreaming Under Anesthesia

This new five-step protocol could make surgery a lot less painful The post The Healing Power of Dreaming Under Anesthesia appeared first on Nautilus.

Jake Currie·Jun 10, 2026

P

ProPublica

A Popular Doctor Had Long Warned That Vitamin K Shots Are Risky for Newborns. Now He’s Changed His Tune.

The post A Popular Doctor Had Long Warned That Vitamin K Shots Are Risky for Newborns. Now He’s Changed His Tune. appeared first on ProPublica.

Duaa Eldeib·Jun 12, 2026

P

ProPublica

Lawmaker Pushes for Ban on Special Treatment for Convicted Drug Traffickers After ProPublica Report

The post Lawmaker Pushes for Ban on Special Treatment for Convicted Drug Traffickers After ProPublica Report appeared first on ProPublica.

Keri Blakinger·Jun 11, 2026

Nautilus

How to Heal People with Science Fiction

A new healthpunk movement aims to teach physicians to use their imaginations The post How to Heal People with Science Fiction appeared first on Nautilus.

Kristen French·Jun 9, 2026